NCT01398462View on ClinicalTrials.gov

Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic SyndromeMyelofibrosis
Interventions
DRUG

CWP232291

IV Infusion

Trial Locations (5)

77030

The University of Texas MD Anderson Cancer Center, Houston

98109

Fred Hutchinson Cancer Research Center, Seattle

Unknown

Asan Medical Center, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

JW Pharmaceutical
All Listed Sponsors
lead

JW Pharmaceutical

INDUSTRY